\n\n\n\n The absence of published human randomized controlled trials for BPC-157 is the most significant gap in the existing evidence base
Flushing IV lines (less common)
TB-500 Coming Soon Oral KPV Coming Soon Peptide therapy may be part of a broader wellness plan that includes nutrition, exercise, sleep, hormone review, medical weight loss support, and follow-up care
Fully achieved reduction of severe lesions in the brain, heart, lungs, liver, kidneys, and gastrointestinal tract reduced thrombosis in both veins and arteries, peripherally and centrally, and fully abrogated intracranial (superior sagittal sinus), portal, and caval hypertension and aortal hypotension may be regarded as a proof of concept
Acknowledgements Grateful thanks are extended to those ALS patients and healthy volunteers who generously donated biosamples for research